查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128965

隱球菌病治療市場：按類型、給藥途徑、治療領域、分銷管道、國家和地區分類－全球產業分析、市場規模、市場佔有率及2026-2033年預測

Cryptococcosis Therapeutics Market, By Type, By Route of Administration, By Therapeutic Area, By Distribution Channel, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 349 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年隱球菌病治療市場價值為14.708億美元，預計從2026年到2033年將以6.1%的複合年成長率成長。

隱球菌藥物有助於治療由真菌引起的嚴重全身性性行為感染。治療包括靜脈注射強效抗真菌藥物，並進行神經系統檢查以控制顱內壓。此治療主要分為三個階段。第一階段是“誘導治療”，使用兩種強效藥物—雙性殺黴素B和Flucytosine—來殺死病原體。第二階段是“維持治療”，使用Fluconazole來殺死病原體。第三階段透過抑制復發來降低復發風險。這種綜合治療方法可以提高隱球菌感染疾病的存活率並降低復發風險。

隱球菌病治療市場 - 市場動態

診斷技術的進步正在推動市場擴張。

診斷影像技術的進步正在推動市場發展，磁振造影（MRI）、電腦斷層掃描（CT）、正子斷層掃描（PET）、超音波和人工智慧成像等尖端技術和新方法能夠實現疾病的快速精準診斷。例如，英國藥品和保健產品監管局（MHRA）在2026年2月報告稱，英國的臨床試驗數量增加了17%。這意味著2025年獲批的申請數量超過了以往任何一年。此外，與前兩年相比，每年與神經技術相關的研究（包括診斷和腦研究）數量也有所增加，佔申請總數的近25%。這些進步正在提高診斷準確性，實現早期發現，並支持更有效的患者照護。

隱球菌病治療市場－市場區隔分析：

全球隱球菌病治療市場按類型、給藥途徑、治療領域、分銷管道和地區進行細分。

按藥物類型分類，抗真菌藥物佔據主要佔有率，因為它們作為一線治療藥物的有效性已得到證實。用於治療的藥物包括Amphotericin B、Flucytosine和Fluconazole。 2025年3月，輝瑞公司在澳洲核准了一種名為CRESEMBA®（硫酸異丁唑啉）的抗黴菌藥物。該藥物屬於唑類，對侵襲性麴菌症和白黴菌症有效。預計這些藥物將有助於擴大抗真菌藥物市場。

在治療領域細分中，愛滋病毒/愛滋病在隱球菌病治療市場佔據重要地位，這主要是由於晚期愛滋病毒/愛滋病患者中隱球菌病的高發病率以及該患者群體對抗真菌治療的巨大需求。例如，2026年8月，印度國家愛滋病控制組織（NACO）愛滋病毒部門報告稱，德里15-49歲族群的愛滋病毒感染率為0.32%，該邦約有58,563名愛滋病毒感染者。據估計，德里每年新增約2,961例愛滋病毒感染病例和1,121例愛滋病毒相關死亡病例。這顯示該地區愛滋病毒/愛滋病的負擔持續加重。隨著愛滋病毒/愛滋病負擔的加重，預計受影響人群對有效隱球菌病治療的需求將會增加。

隱球菌病治療市場—區域分析

北美擁有許多致力於研發隱球菌病治療方法的領導企業和研究機構。公共衛生機構與製藥公司之間也進行了多項合作計畫。例如，根據世界衛生組織（世衛組織）統計，截至2026年1月，已有超過150個國家採用世衛組織基本藥物示範清單制定了本國基本藥物清單，這意味著超過150個國家採納了基於世衛組織示範清單的「國家基本藥物清單」。 「2025年世衛組織基本藥物示範清單」收錄了超過520種藥物，其中374種為兒童用藥。這些努力正在加速治療方法的研發，改善藥物的可近性，並支持北美地區隱球菌病管理系統的完善。

目錄

第1章：隱球菌病治療市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：隱球菌病治療市場的主要趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：隱球菌病治療產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：隱球菌病治療市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：隱球菌病治療藥物的市場趨勢

  • 隱球菌病治療市場佔有率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 隱球菌病治療市場：依類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按類型
    • 聯合治療
    • 免疫療法
    • 抗真菌劑

第8章：隱球菌病治療市場：依給藥途徑分類

  • 概述
    • 按給藥途徑分類的市佔率分析
    • 靜脈
    • 外用
    • 口服

第9章：隱球菌病治療市場：依治療領域分類

  • 概述
    • 按治療區域分類的市佔率分析
    • 移植
    • 免疫力缺乏患者
    • 愛滋病毒/愛滋病

第10章：隱球菌病治療市場：依分銷管道分類

  • 概述
    • 基於細分市場的市場佔有率分析：按分銷管道分類
    • 藥局
    • 網路藥房
    • 醫院

第11章 隱球菌病治療市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第12章：主要供應商分析：隱球菌病治療產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Gilead Sciences, Inc.
    • Merck & Co., Inc.
    • Asahi Kasei Pharma Corporation
    • Sun Pharmaceutical Industries Limited
    • Dr. Reddy's Laboratories Ltd.
    • Cipla Limited
    • Basilea Pharmaceutica AG
    • F2G Limited
    • Matinas BioPharma Holdings Inc.
    • Lupin Limited
    • Bausch Health Companies Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
    • Amplyx Pharmaceuticals, Inc.
    • Flynn Pharma Ltd.
    • NuCare Pharmaceuticals, Inc.
    • Sanofi
    • Abbott Laboratories
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7389

Cryptococcosis Therapeutics Market size was valued at US$ 1,470.8 Million in 2025, expanding at a CAGR of 6.1% from 2026 to 2033.

Cryptococcosis therapeutics help in the treatment of a serious systemic infection that is brought about by the fungi with the aid of potent antifungal agents intravenously and neurological testing in order to manage intracranial pressure. This method is comprised of three main steps. The first step of the method involves induction, in which the use of two powerful drugs, amphotericin B and flucytosine, is employed in an attempt to kill the organisms. The second phase includes the consolidation phase, which involves the administration of fluconazole to kill the organism. The third phase involves reducing the risk of recurrence through the reduction of relapse. This comprehensive treatment approach improves survival outcomes and reduces recurrence risks in cryptococcal infections.

Cryptococcosis Therapeutics Market- Market Dynamics

Advancements In Diagnostic Techniques To Boost Market Expansion

Advancements in diagnostic techniques are driving the diagnostic imaging market, as newer technologies and new techniques such as MRI, CT, PET, ultrasound, and imaging using AI technology provide for rapid and accurate diagnosis of diseases. For example, in February 2026, the Medicines and Healthcare Products Regulatory Agency (MHRA), per the UK government, reported a 17% growth in the number of clinical investigation trials in the UK, which means that more applications have been approved in 2025 than in any other year before. Moreover, there has been a rise in the number of neurotechnology investigations (both diagnostics and brain research) in a year compared to the past two years; the increment has accounted for nearly 25% of their total applications. These advancements are improving diagnostic accuracy, enabling earlier detection, and supporting more effective patient care.

Cryptococcosis Therapeutics Market- Segmentation Analysis:

The Global Cryptococcosis Therapeutics Market is segmented on the basis of Type, Route of Administration, Therapeutic Area, Distribution Channel, and Region.

Among the given types, antifungal agents hold a major share under the type segment because of their proven use as the first-line treatment for the disease. The drugs used in the treatment include amphotericin B, flucytosine, and fluconazole. In March 2025, Pfizer Inc. was granted Australian approval of its antifungal agent known as CRESEMBA(R) (isavuconazonium sulfate). This antifungal belongs to the azole family that acts against invasive aspergillosis and mucormycosis. These will help in increasing the antifungal agents segment.

HIV/AIDS holds the key position in the Cryptococcosis Therapeutics Market under the Therapeutic Area segment, driven by the high incidence of cryptococcal disease among people with advanced HIV/AIDS and the significant need for antifungal treatment in this population. For instance, in August 2026, according to the Delhi State AIDS Control Society (Gov.), NACO HIV reported that Delhi had an HIV prevalence of 0.32% among the aged 15-49 years, which amounted to approximately 58,563 people living with HIV in the state. In Delhi the estimations suggested around 2,961 new HIV infections per year and approximately 1,121 deaths due to HIV per year. It shows that the burden of HIV/AIDS is continually increasing in the region. This rising HIV/AIDS burden is expected to increase demand for effective cryptococcosis therapeutics among affected patients.

Cryptococcosis Therapeutics Market- Geographical Insights

North America is home to leading pharmaceutical companies and research institutions that actively participate in creating treatments for cryptococcosis. There are some joint ventures between the public health institutions and the pharmaceutical firms. For example, in January 2026, according to the World Health Organization (WHO), more than 150 nations have adopted their national lists of essential medicines using the model list issued by the WHO, meaning that more than 150 countries use the National List of Essential Medicines developed based on the WHO Model List. The WHO Model List of Essential Medicines 2025 includes more than 520 medicines, of which 374 are children's medicines. These initiatives strengthen treatment development, improve access, and support better cryptococcosis management across North America.

Cryptococcosis Therapeutics Market- Competitive Landscape:

The Cryptococcosis Therapeutics market is also working towards making acquisitions, particularly in the drug categories and geographies. The leading companies operating in this market are Astellas Pharma Inc., Bristol-Myers Squibb Company, Glenmark Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc., and these companies are looking towards increasing the efficacy of treatment of the disease that causes cryptococcosis. In November 2025, Merck & Co., Inc. entered into a partnership with Cidara Therapeutics for strengthening its antifungal product portfolio through CD421, which is an echinocandin in development for the treatment of serious fungal infections. These strategic initiatives are expected to strengthen antifungal treatment options and support continued market growth.

Recent Developments:

In February 2026, the investigational oral amphotericin B drug MAT2203 from Matinas BioPharma was featured in a published clinical case report for its successful treatment of cryptococcal meningitis, proving its worth as an oral drug for the treatment of cryptococcosis.

In September 2025, Basilea Pharmaceutica AG received an additional USD 25 million grant funding from the Biomedical Advanced Research and Development Authority (BARDA) for the development of its novel antifungal agents fosmanogepix and BAL2062 for treating tough-to-treat cases of fungal infection, including cryptococcosis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Asahi Kasei Pharma Corporation
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited
  • Basilea Pharmaceutica AG
  • F2G Limited
  • Matinas BioPharma Holdings Inc.
  • Lupin Limited
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Amplyx Pharmaceuticals, Inc.
  • Flynn Pharma Ltd.
  • NuCare Pharmaceuticals, Inc.
  • Sanofi
  • Abbott Laboratories
  • Others

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Combination Therapy
  • Immunotherapy
  • Antifungal Agents

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033

  • Intravenous
  • Topical
  • Oral

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2020 - 2033

  • Transplantation
  • Immunocompromised Patients
  • HIV/AIDS

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033

  • Pharmacies
  • Online Pharmacies
  • Hospitals

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Cryptococcosis Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Cryptococcosis Therapeutics Key Market Trends

  • 3.1. Cryptococcosis Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cryptococcosis Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cryptococcosis Therapeutics Market Opportunities
  • 3.4. Cryptococcosis Therapeutics Market Future Trends

4. Cryptococcosis Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cryptococcosis Therapeutics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cryptococcosis Therapeutics Market Landscape

  • 6.1. Cryptococcosis Therapeutics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cryptococcosis Therapeutics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Combination Therapy
    • 7.1.3. Immunotherapy
    • 7.1.4. Antifungal Agents

8. Cryptococcosis Therapeutics Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
    • 8.1.2. Intravenous
    • 8.1.3. Topical
    • 8.1.4. Oral

9. Cryptococcosis Therapeutics Market - By Therapeutic Area

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapeutic Area, 2025 & 2033 (%)
    • 9.1.2. Transplantation
    • 9.1.3. Immunocompromised Patients
    • 9.1.4. HIV/AIDS

10. Cryptococcosis Therapeutics Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
    • 10.1.2. Pharmacies
    • 10.1.3. Online Pharmacies
    • 10.1.4. Hospitals

11. Cryptococcosis Therapeutics Market - By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cryptococcosis Therapeutics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cryptococcosis Therapeutics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cryptococcosis Therapeutics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Cryptococcosis Therapeutics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Cryptococcosis Therapeutics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Cryptococcosis Therapeutics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Gilead Sciences, Inc.
    • 12.2.2. Merck & Co., Inc.
    • 12.2.3. Asahi Kasei Pharma Corporation
    • 12.2.4. Sun Pharmaceutical Industries Limited
    • 12.2.5. Dr. Reddy's Laboratories Ltd.
    • 12.2.6. Cipla Limited
    • 12.2.7. Basilea Pharmaceutica AG
    • 12.2.8. F2G Limited
    • 12.2.9. Matinas BioPharma Holdings Inc.
    • 12.2.10. Lupin Limited
    • 12.2.11. Bausch Health Companies Inc.
    • 12.2.12. Teva Pharmaceutical Industries Ltd.
    • 12.2.13. Viatris Inc.
    • 12.2.14. Amplyx Pharmaceuticals, Inc.
    • 12.2.15. Flynn Pharma Ltd.
    • 12.2.16. NuCare Pharmaceuticals, Inc.
    • 12.2.17. Sanofi
    • 12.2.18. Abbott Laboratories
    • 12.2.19. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us